Search clinical trials for: Volunteers presenting moderate primary insomnia

Total 31780 results

Arctic Bioscience
Smerud Medical Research International AS

Active, not recruiting

Efficacy and Safety Study of HRO350 in Patients With Mild-to-moderate Psoriasis (the 'HeROPA' Study). (HeROPA)

Psoriasis

Poland, Germany, United Kingdom, Norway, Finland
University Hospital, Brest

Terminated

Impact of a Brief Motivational Intervention Including Counter-marketing Arguments With a Population of Patients With Moderate to Severe Alcohol Use Disorders Who Are Followed up on an Outpatient Basis (Primary Care or Addictology) (DEPREV_Phase 3)

Addiction, Alcohol

France
Astellas Pharma Global Development, Inc.

Completed

A Study to Investigate the Effect of Mild and Moderate Hepatic Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Hepatic Function

Healthy Volunteers | Hepatic Impairment

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older

Influenza | Healthy Volunteers

United States
Seattle Children's Hospital
University of Virginia

Active, not recruiting

Intervention for Sleep and Pain in Youth: A Randomized Controlled Trial (I-SPY-RCT)

Migraine Disorders | Insomnia | Headache Disorders

United States
KBP Biosciences

Active, not recruiting

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe CKD (Clarion-CKD)

Chronic Kidney Diseases

China, Spain, Australia, Hungary, Malaysia, United States, Germany, Bulgaria, Serbia, Hong Kong, Georgia, Bosnia and Herzegovina, Croatia, Czechia, South Africa, Canada, Israel, Korea, Republic of, Latvia, Lithuania, Poland, Taiwan
National Cancer Institute (NCI)

Completed

Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma

Brain Stem Glioma | Childhood Spinal Cord Neoplasm | Childhood Cerebral Anaplastic Astrocytoma | Cerebral Astrocytoma | Childhood Cerebellar Anaplastic Astrocytoma

United States, Canada
Woolcock Institute of Medical Research
University of Sydney

Completed

Cannabinol Use in Patients With Insomnia Disorder (CUPID)

Insomnia Disorder

Australia
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge

Terminated

Molecular Investigation of Genetic Factors in CArDiovascular Diseases Using an BIOresource of Healthy Volunteers (CADBIO)

Cardiovascular Diseases

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

An Observational Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis in Persons Aged > / = 14 Years Presenting With Community Acquired Pneumonia (CAP) in Endemic Areas (SAnds-PPC)

Pneumonia | Coccidioidomycosis

United States
Hospices Civils de Lyon

Withdrawn

tDCS and Prismatic Adaptation: Roles of the Cerebellum and the Primary Motor Cortex in the Transfer of After-effects (TRANSTIM)

Healthy Volunteers

France
Seneque SA
CEN Nutriment; LGD; Centre d'Expertise de la Performance

Completed

Effect of NMN on Muscle Recovery and Physical Capacity in Healthy Volunteers With Moderate Physical Activity

Physical Activity | Muscle Recovery

France
Henry Ford Health System
Robert Wood Johnson Foundation

Completed

Sleep to Prevent Evolving Affecting Disorders (SPREAD)

Depression | Insomnia, Primary

United States
CSL Behring

Completed

A Clinical Study to Test the Safety, Exposure, and Pharmacodynamic Markers of CSL311 in Patients With Mild-to-moderate Asthma and in Healthy Volunteers

Asthma

United Kingdom, Germany
NYU Langone Health
National Heart, Lung, and Blood Institute (NHLBI); Center for Advancing Point...

Completed

RELAXaHEAD for Headache Patients (Phase II)

Multiple Sclerosis | Migraine | Insomnia | Headache

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49

Meningococcal Infection (Healthy Volunteers)

Puerto Rico, United States
BeiGene

Completed

The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males

Healthy | Male

United States
Insel Gruppe AG, University Hospital Bern

Active, not recruiting

Muscular and Cutaneous Dysfunction in POTS

Postural Tachycardia Syndrome

Switzerland
Pharmacyclics LLC.
Janssen Research & Development, LLC

Active, not recruiting

Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)

Chronic Graft Versus Host Disease

United States, Spain, Korea, Republic of, Australia, Austria, Canada, France, Germany, Israel, Italy, Netherlands, Russian Federation, United Kingdom
National Jewish Health
Stanford University

Active, not recruiting

Therapist-Directed VS Online Therapy for Insomnia Co-Occuring With Sleep Apnea

Sleep Apnea, Obstructive | Insomnia, Primary

United States
Millennium Pharmaceuticals, Inc.

Completed

A Study to Evaluate Pharmacokinetics (PK) and Safety of Oral Mobocertinib in Participants With Moderate or Severe Hepatic Impairment (HI) and Normal Hepatic Function

Healthy Volunteers | Hepatic Impairment

United States
Bristol-Myers Squibb

Completed

A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants

Healthy Volunteers

United States
VA Office of Research and Development
Minneapolis Veterans Affairs Medical Center; VA Pittsburgh Healthcare System; Corporal Michael J. Crescenz VA Medical Center and other collaborators

Active, not recruiting

Enhancing Access to Insomnia Care in VA PCMHI Clinics (EASI Care)

Chronic Insomnia

United States
The Hong Kong Polytechnic University

Completed

Effects of Messaging App Reminder on the Compliance of Zero-Time Exercise (ZTEx)

Insomnia, Primary

Hong Kong
Sanofi Pasteur, a Sanofi Company

Completed

Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)

Meningococcal Immunisation (Healthy Volunteers)

United States, Puerto Rico
Universitaire Ziekenhuizen KU Leuven
European Commission

Completed

European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer (EUDARIO)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

Germany, Belgium, Italy, Austria, France
Portola Pharmaceuticals
Novartis

Terminated

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

Renal Impairment

United States
VA Office of Research and Development
VA Connecticut Healthcare System; US Department of Veterans Affairs

Completed

Implementing and Evaluating Computer-Based Interventions for Mental Health: Testing an Implementation Strategy for VA Outpatient Care

Insomnia

United States
Henry Ford Health System
University of Michigan; Big Health Inc.

Active, not recruiting

Sleep To Reduce Incident Depression Effectively (STRIDE)

Major Depressive Disorder | Rumination | Insomnia, Primary

United States
Saglik Bilimleri Universitesi

Completed

The Effects of Milk and Banana as a Night Meal to Primary Insomnia on Sleep Quality, BDNF and Appetite Mechanism (diet)

Primary Insomnia

Turkey
Cara Therapeutics, Inc.

Terminated

Study to Evaluate the Safety and Efficacy of Oral CR845 (Difelikefalin) in Patients With Primary Biliary Cholangitis (PBC) and Moderate-to-Severe Pruritus

Cholestatic Pruritus

United States
Epizyme, Inc.

Completed

Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients

Mantle Cell Lymphoma | Marginal Zone Lymphoma | Advanced Solid Tumor | Diffuse Large B Cell Lymphoma | Primary Mediastinal Lymphoma

United States
The Hong Kong Polytechnic University

Completed

Effects of Zero-Time Exercise (ZTEx) on Inactive Adults With Insomnia Disorder

Insomnia, Primary

Hong Kong
USGI Medical

Active, not recruiting

A Feasibility Study for the Treatment of Primary Obesity

Obesity

United States
Christina Murphey, RN, PhD

Suspended

New Mothers Alpha-Stim

Depression | Insomnia | Anxiety | Sleep Quality

United States
Bayer

Withdrawn

A Study to Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Kidney Function

Renal Impairment | Healthy Volunteers | Diabetic Neuropathic Pain

United States
Pacific Institute of Medical Sciences

Terminated

Comparison of Efficacy of Behavioral Approaches for Treatment of Insomnia (CEBATI)

Primary Insomnia

United States
M.D. Anderson Cancer Center

Withdrawn

The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms

Malignant Neoplasms of Independent (Primary) Multiple Sites

United States
Celgene
Impact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation

Completed

A Pharmacokinetics and Tolerability Study of Fedratinib in Subjects With Moderate and Severe Hepatic Impairment

Healthy Volunteers | Hepatic Impairment

United States
Reistone Biopharma Company Limited

Completed

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

Crohn's Disease

China, Poland, Ukraine, United States
Astellas Pharma Global Development, Inc.

Completed

A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy People

Renal Impairment | Healthy Volunteers

United States
Chiesi Farmaceutici S.p.A.

Completed

PK of CHF6001 in Subjects With Mild, Moderate and Severe Renal Impairment vs. Healthy Volunteers

Chronic Obstructive Pulmonary Disease

Bulgaria
Astellas Pharma Global Development, Inc.

Completed

A Study to Evaluate ASP0367 in Participants With Mild/Moderate Hepatic Impairment Compared to Participants With Normal Hepatic Function

Healthy Volunteers | Hepatic Impairment

United States
GlaxoSmithKline

Completed

Phase I Study of Linerixibat in Adults With Moderate Hepatic Impairment and Healthy Controls

Pruritus

United States
60 Degrees Pharmaceuticals LLC

Completed

Tafenoquine in Patients With Mild to Moderate COVID-19

COVID 19 Disease

United States
University of Pennsylvania
Doris Duke Charitable Foundation

Completed

Effects of Insomnia Treatment on Metabolism in Patients With Depression

Depression | Insomnia | Depressive Symptoms | Insomnia Chronic | Insomnia, Primary

United States
Virginia Commonwealth University

Completed

CBT for Insomnia in Primary Brain Tumor Patients

Primary Brain Tumor | PBT

United States
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

Study on Human Mass Balance of SPH3127 Tablets

Primary Mild and Moderate Hypertension

China
Rhythm Pharmaceuticals, Inc.

Completed

Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers

Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations

United States, Israel, Canada, Germany, Greece, Italy, Portugal
Kowa Research Institute, Inc.

Completed

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

Severe Hypertriglyceridemia

United States, Czechia, Belarus, Hungary, Russian Federation, Poland, Bulgaria, Georgia, Ukraine

Search clinical trials for: Volunteers presenting moderate primary insomnia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations